Unlock more results with a Fundz subscription — Get started today!
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Love Pharma Inc. Announces First Closing Of Financing
04/05/22, 5:25 PM
Location
vancouverVANCOUVER, BC / April 5, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed a first closing of a non-brokered private placement. The Company accepted subscriptions for 16,550,000 units at a price of $0.02 per unit, for gross proceeds of $331,000. Each unit consists of one common share and one common share purchase warrant
Company Info
Location
vancouver, washington, united states
Additional Info
With a focus on the global sexual Health and Wellness markets, Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) was founded in 2020, with a mission to bring to market innovative products that enhance sexual health and wellness while providing an improved quality of life. Love Pharma holds exclusive licenses to produce market, package, sell, and distribute patent-protected therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America.
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.